I’ve Tried Three Antidepressants and Nothing Works. What Are My Options?

You still have options. When two or more antidepressants have not worked, providers call it treatment-resistant depression. There are treatments made specifically for it, including two that are not pills: TMS and Spravato.

What counts as an antidepressant that “did not work”

A medication only counts if you reached a full dose and stayed on it six to eight weeks. Many trials never got that far:

• Side effects made you stop
• The dose never got raised
• Cost or a pharmacy gap interrupted it
• You lost hope and stopped

Most people have had fewer real trials than they think. That is the first thing to sort out.

What to check before adding anything new

Something else going on? Bipolar disorder, ADHD, PTSD, OCD, or alcohol and substance use all change what works. Antidepressants alone often disappoint when one of these is missed.

Something medical? Thyroid problems, sleep apnea, low iron, low vitamin D, and chronic pain can all drive depression. Worth testing, not assuming.

What is left to try

• Raise the dose on what you already take, if it never got high enough
• Switch classes to a medication that works differently
• Add a second medication if your current one helps a little
• TMS therapy. Magnetic pulses, awake in a chair, drive yourself home. FDA-cleared for adult depression, as an add-on for adult OCD, and for teens 15 to 21. Across 307 patients at 42 clinics, 58 percent improved and 37 percent reached remission (Carpenter 2012)
• Spravato (esketamine). Nasal spray in our office, about two hours of monitoring, ride home required. FDA-approved for treatment-resistant depression and for depression with active suicidal thoughts. Adding it beat the antidepressant alone in the approval trial (Popova 2019)

If none of these fit, other options exist and a psychiatric provider can walk you through them.

Why not just try a fifth antidepressant?

You can, and sometimes it works. But the odds drop each round. In the STAR*D study, about 37 percent got well on the first medication and only 14 and 13 percent on the third and fourth (Rush 2006). That is why providers start looking at different approaches instead of pill number five.

Which option is right for you?

It usually comes down to:

• How many real medication trials you have had
• How severe things are, especially any suicidal thoughts
• Whether pills have been hard to tolerate
• How fast you need relief
• Whether you can get a ride on treatment days
• What your insurance approves

The last two decide more cases than people expect. See fees and insurance for the plans we take. We verify benefits and handle prior authorization before you start.

What happens at your first visit

We review every medication you tried, the dose, and why it stopped. We look at the diagnosis fresh. Then we tell you which options fit you, in what order, and what each costs.

If you have been feeling hopeless or thinking of hurting yourself, say so at that visit. It changes what we recommend. If you are in danger now, call or text 988.

Common questions

How many antidepressants do I need to try first?

Two real trials is the usual threshold for insurance and for TMS or Spravato. Real means a full dose, long enough.

Do I stop my current medication?

Usually no. Most people stay on their antidepressant during TMS or Spravato.

Will insurance make me fail more medications first?

Some plans require documented past trials before approving TMS or Spravato. It varies. We check your plan and handle the paperwork.

How long before I know it is working?

Medication changes take a few weeks to judge. TMS runs several weeks. Spravato starts twice weekly.

Is treatment-resistant depression permanent?

No. It describes what has happened so far. Many people who failed several antidepressants respond to treatment-resistant depression care that goes beyond pills.

References

• Rush AJ, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905-1917. PubMed
• Carpenter LL, et al. Transcranial magnetic stimulation for major depression: a multisite, naturalistic, observational study. Depress Anxiety. 2012;29(7):587-596. Journal
• Popova V, et al. Efficacy and safety of flexibly dosed esketamine nasal spray in treatment-resistant depression. Am J Psychiatry. 2019;176(6):428-438. PubMed

Medically reviewed by Nefretiri Abat, J.D., PMHNP-BC, board-certified Psychiatric-Mental Health Nurse Practitioner.